In their studies, Zhou et al. and Xie et al. showed that the association of ATRX and IDH mutations, particularly in young patients, had a better prognosis and was associated with a high survival rate in grade 4 astrocytoma [8, 9]. The gene discussed is ATRX; the disease is astrocytoma (excluding glioblastoma).